BSE Live
Jan 30, 16:01Prev. Close
21.97
Open Price
21.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Beryl Drugs (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.08 | 0.03 | 0.07 | 0.09 | 0.01 | |
| Net CashFlow From Operating Activities | 0.41 | 0.34 | 0.24 | 0.54 | 0.37 | |
| Net Cash Used In Investing Activities | -0.23 | -0.30 | -0.40 | -0.39 | -0.56 | |
| Net Cash Used From Financing Activities | -0.27 | 0.04 | -0.06 | -0.16 | 0.17 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.10 | 0.09 | -0.22 | -0.02 | -0.02 | |
| Cash And Cash Equivalents Begin of Year | 0.15 | 0.06 | 0.28 | 0.30 | 0.32 | |
| Cash And Cash Equivalents End Of Year | 0.05 | 0.15 | 0.06 | 0.28 | 0.30 |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y